Abstract

Cells employ global genome nucleotide excision repair (GGR) to eliminate a broad spectrum of DNA lesions, including those induced by UV light. The lesion-recognition factor XPC initiates repair of helix-destabilizing DNA lesions, but binds poorly to lesions such as CPDs that do not destabilize DNA. How difficult-to-repair lesions are detected in chromatin is unknown. Here, we identify the poly-(ADP-ribose) polymerases PARP1 and PARP2 as constitutive interactors of XPC. Their interaction results in the XPC-stimulated synthesis of poly-(ADP-ribose) (PAR) by PARP1 at UV lesions, which in turn enables the recruitment and activation of the PAR-regulated chromatin remodeler ALC1. PARP2, on the other hand, modulates the retention of ALC1 at DNA damage sites. Notably, ALC1 mediates chromatin expansion at UV-induced DNA lesions, leading to the timely clearing of CPD lesions. Thus, we reveal how chromatin containing difficult-to-repair DNA lesions is primed for repair, providing insight into mechanisms of chromatin plasticity during GGR.

Cells employ global genome nucleotide excision repair to repair a broad spectrum of genomic DNA lesions. Here, the authors reveal how chromatin is primed for repair, providing insight into mechanisms of chromatin plasticity during DNA repair.

Details

Title
XPC–PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair
Author
Blessing, Charlotte 1   VIAFID ORCID Logo  ; Apelt, Katja 2 ; van den Heuvel, Diana 2 ; Gonzalez-Leal, Claudia 1 ; Rother, Magdalena B. 2 ; van der Woude, Melanie 3 ; González-Prieto, Román 4   VIAFID ORCID Logo  ; Yifrach, Adi 5 ; Parnas, Avital 5 ; Shah, Rashmi G. 6 ; Kuo, Tia Tyrsett 1   VIAFID ORCID Logo  ; Boer, Daphne E. C. 2 ; Cai, Jin 1 ; Kragten, Angela 2 ; Kim, Hyun-Suk 7 ; Schärer, Orlando D. 8 ; Vertegaal, Alfred C. O. 9 ; Shah, Girish M. 6   VIAFID ORCID Logo  ; Adar, Sheera 5 ; Lans, Hannes 3   VIAFID ORCID Logo  ; van Attikum, Haico 2 ; Ladurner, Andreas G. 10   VIAFID ORCID Logo  ; Luijsterburg, Martijn S. 2   VIAFID ORCID Logo 

 Faculty of Medicine, LMU Munich, Biomedical Center (BMC), Physiological Chemistry, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); International Max Planck Research School (IMPRS) for Molecular Life Sciences, Planegg-Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091) 
 Leiden University Medical Center (LUMC), Department of Human Genetics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
 Erasmus University Medical Center, Department of Molecular Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 Leiden University Medical Center (LUMC), Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978); Andalusian Center For Molecular Biology and Regenerative Medicine (CABIMER), University of Seville, Genome Proteomics Laboratory, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); University of Seville, Department of Cell Biology, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229) 
 The Hebrew University of Jerusalem, Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, Jerusalem, Israel (GRID:grid.9619.7) (ISNI:0000 0004 1937 0538) 
 CHU-Q: Laval University Hospital Research Centre of Quebec (CHUL site), Laboratory for Skin Cancer Research, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390) 
 Institute for Basic Science, Center for Genomic Integrity, Ulsan, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496) 
 Institute for Basic Science, Center for Genomic Integrity, Ulsan, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496); Ulsan National Institute of Science and Technology, Department of Biological Sciences, School of Life Sciences, Ulsan, Republic of Korea (GRID:grid.42687.3f) (ISNI:0000 0004 0381 814X) 
 Leiden University Medical Center (LUMC), Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
10  Faculty of Medicine, LMU Munich, Biomedical Center (BMC), Physiological Chemistry, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); International Max Planck Research School (IMPRS) for Molecular Life Sciences, Planegg-Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091); Eisbach Bio GmbH, Planegg-Martinsried, Germany (GRID:grid.511157.6) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2701621993
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.